[Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
Rotenberger
J
J
Medizinische Klinik, Ferdinand-Sauerbruch-Klinikum Wuppertal, Adademisches Lehrkrankenhaus der Heinrich-Heine-Universität Düsseldorf.
Köbberling
J
J
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*; D011282:Pregnenediones / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D013810:Therapeutic Equivalency
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011282:Pregnenediones; C021988:deflazacort